AGEN Stock Analysis: Buy, Sell, or Hold?
AGEN - Agenus Inc.
$7.82
0.32 (4.27%)
▲
5d:
+27.57%
30d:
+124.07%
90d:
+103.65%
WAIT
LOW Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 06, 2026
1d
Get Alerted When AGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: AGEN is 20.3% above its trading range ($6.50). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: AGEN is 20.3% above its trading range ($6.50). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: AGEN is currently trading at $7.82, which is considered extended relative to its 30-day fair value range of $3.34 to $6.50. From a valuation perspective, the stock is trading at a discount (Forward PE: -130.3) compared to its historical average (5.1). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AGEN is in a uptrend. Immediate support is located at $4.99, while resistance sits at $8.09. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: AGEN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $22.00 (+181.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AGEN is in a uptrend. Immediate support is located at $4.99, while resistance sits at $8.09. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: AGEN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $22.00 (+181.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.34 -
$6.50
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
Protect Your Profits
AGEN is technically overbought (RSI 76). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+20.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.3%)
- BULLISH: Trading 181.3% below Wall St target ($22.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Recommendation downgraded due to 20.3% overvaluation
Trading Range Analysis
30-Day Trading Range
$3.34 -
$6.50
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.99
Resistance Level
$8.09
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-130.33
Wall Street Target
$22.00
(+181.3%)
Revenue Growth (YoY)
40.2%
Profit Margin
52.2%
PE vs Historical
-130.3 vs 5.1
CHEAP
Share & Embed Analysis
Last updated: August 04, 2026 8:48 AM ET
Data refreshes hourly during market hours. Next update: 9:48 AM
Data refreshes hourly during market hours. Next update: 9:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 56 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 56 HOLD |
Advanced AGEN Option Strategies
Professional options setups generated by AI based on today's AGEN price and gamma walls.
